Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Hans Wedel's publication output changed over time?
ScholarIQpublication output · 1995–2012
Output grew0% over the shown period — from 1 works in 1995 to 1 in 2012.
1
1
1
1
2
1
1
1
2
1
1995199619982000200220032004200520072012
What are the most-cited papers on Hans Wedel?
ScholarIQmost cited works
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Lennart Hansson, Alberto Zanchetti, S. George Carruthers, Björn Dahlöf, Dag Elmfeldt, Stevo Julius, Joël Ménard, K. H. Rahn, Hans Wedel, S. Westerling
The Lancet. 19985,791 Citations
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen, Stevo Julius, Gareth Beevers, Ulf dé Fairé, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe‐Pedersen, Lars Lindholm, Markku S. Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel
The Lancet. 20025,421 Citations
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Lars Sjöström, Kristina Narbro, C. David Sjöström, Kristjan Karason, Bo Larsson, Hans Wedel, Ted Lystig, Marianne Sullivan, Claude Bouchard, Björn Carlsson, Calle Bengtsson, S Dahlgren, Anders Gummesson, Peter Jacobson, Jan Karlsson, Anna‐Karin Lindroos, Hans Lönroth, Ingmar Näslund, Torsten Olbers, Kaj Stenlöf, Jarl Torgerson, Göran I. Ågren, Lena Carlsson
New England Journal of Medicine. 20074,645 CitationsOPEN ACCESS
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
Lars Sjöström, Anna‐Karin Lindroos, Markku Peltonen, Jarl Torgerson, Claude Bouchard, Björn Carlsson, S Dahlgren, Bo Larsson, Kristina Narbro, Carl David Sjöström, Marianne Sullivan, Hans Wedel
New England Journal of Medicine. 20044,472 CitationsOPEN ACCESS
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
Peter Sever, Björn Dahlöf, Neil R Poulter, Hans Wedel, Gareth Beevers, Mark J. Caulfield, Rory Collins, Sverre E. Kjeldsen, Arni Kristinsson, Gordon T. McInnes, Jesper Mehlsen, Markku S. Nieminen, Eoin OʼBrien, Jan Östergren
The Lancet. 20033,792 Citations
Related on ScholarIQ
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Paper
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Paper
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Paper
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
Paper
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
Paper
Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures
Paper